Pulmonary response of severely asthmatic horses after intra-articular administration of methylprednisolone.

Summary

# Pulmonary Response of Severely Asthmatic Horses After Intra-articular Administration of Methylprednisolone Corticosteroid injections into joints are standard practice in equine medicine, yet their systemic effects remain incompletely understood. Previous research demonstrated that intra-articular triamcinolone acetonide improved lung function in horses with severe equine asthma; Millares-Ramirez and colleagues investigated whether methylprednisolone acetate (MPA)—another widely-used intra-articular corticosteroid—might produce similar pulmonary benefits in this population. Using severe asthmatic horses as subjects, the researchers administered IA MPA and assessed airway obstruction via pulmonary function testing. The findings revealed that, contrary to their hypothesis, IA MPA did not significantly reduce airway obstruction in severely asthmatic horses, distinguishing it from the therapeutic effects previously observed with IA triamcinolone acetonide. This discrepancy between corticosteroid formulations has important implications: practitioners should recognise that systemic anti-inflammatory effects from intra-articular injections cannot be assumed across all corticosteroid preparations, and horses with concurrent severe asthma may warrant particular attention to drug selection and monitoring when joint injections are indicated.

Read the full abstract on PubMed

Key Findings

• •Study hypothesized that intra-articular methylprednisolone acetate would decrease airway obstruction in severe asthmatic horses, based on prior evidence of IA triamcinolone acetonide improving lung function
• •Research addresses potential systemic pulmonary effects of commonly used intra-articular corticosteroids in equine practice

Conditions Studied

Tags